Close

Abbott India Confirms Drugs Are Fake And Not Their Make

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

O-1A Visa Evidence for Pharma and Biotech Professionals: What Actually Proves Extraordinary Ability

Important pharmaceutical work is not always publicly visible. A medicinal...

CDSCO to Introduce Integrated Drug Regulatory Platform in 18 Months

The Central Drugs Standard Control Organisation (CDSCO) has announced...

Resilience and Eli Lilly Expand Strategic Partnership with $750 Million Ohio Manufacturing Investment

Resilience has announced an expansion of its strategic partnership...
- Advertisement -

Abbott informed yesterday, July 3rd, that there are several ways to tell if a customer’s pack of Thyronorm is authentic or fake. The label of the product has a QR code that, when scanned, opens a homepage with a video demonstrating the advantages of the flip-top pack. On the cap, a real Abbott emblem attests to the legitimacy of the pack, the company added.

This comes after questions concerning the genuinity of its drug Thyronorm were raised across the Indian state of Telengana. The pharma giant said that not only in Telangana, but pharmacies all over India continue to carry authentic and premium Thyronorm. They will keep working to warn authorities about counterfeiters for the protection and welfare of their patients.

The company confirmed that Thyronorm batches listed by Telangana’s Drugs Control Administration (DCA) as not meeting quality standards were neither produced nor distributed by the manufacturer and are therefore fakes. It also claimed to have informed the authorities about the availability of fake products on the market. A business representative confirmed thatย the batches of Thyronorm listed on the drugs control administration (DCA) government of Telangana list were undoubtedly fake and neither produced nor distributed by Abbott. The integrity of genuine Abbott products remains unaffected. In this instance, they contacted authorities preemptively about these potentially fake medications, and appropriate measures have been taken.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Latest stories

Related stories

O-1A Visa Evidence for Pharma and Biotech Professionals: What Actually Proves Extraordinary Ability

Important pharmaceutical work is not always publicly visible. A medicinal...

CDSCO to Introduce Integrated Drug Regulatory Platform in 18 Months

The Central Drugs Standard Control Organisation (CDSCO) has announced...

Resilience and Eli Lilly Expand Strategic Partnership with $750 Million Ohio Manufacturing Investment

Resilience has announced an expansion of its strategic partnership...

WHO Introduces Global Regulatory Framework for Decarbonizing Pharmaceuticals

The World Health Organization (WHO) has officially launched the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป